International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential

- Qi Z. , et al.

2. Repurposing anti-diabetic agents: Investigating their therapeutic utility in managing co-occurring conditions in diabetes

- Das A. , et al.

3. Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study

- Gul N. , et al.

4. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

- Das A.K. , et al.

5. Association between sodium-glucose cotransporter 2 inhibitors and pancreatic cancer in the Japanese working-age population

- Tanaka Y. , et al.

6. Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): A multicenter, randomized, open-label, parallel-group study

- Kudo A. , et al.

7. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019

- Park J. , et al.

8. The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis

- Alhindi Y. , et al.

9. Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review

- Jamrozik D. , et al.

10. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

- Sendekie A.K. , et al.

11. SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD

- Ala M. , et al.

12. Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis

- Gabler M. , et al.

13. Disproportionality analysis of spontaneously reported hypoglycemia events due to insulin use: A comparison between insulin detemir and insulin degludec using the Korea Adverse Event Reporting System

- Jeong D.W. , et al.

14. Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non-interventional comparative study

- Shaik Alavudeen S. , et al.

15. A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey

- Mosslemi M. , et al.

16. Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients

- Alavudeen S.S. , et al.

17. Hypoglycemic effect of calendula arvensis flowers is mediated by digestive enzyme inhibition

- Abudunia A.M. , et al.

18. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction

- Packer M. , et al.

19. SGLT2 inhibitors: oral antidiabetic agent and/or treatment in the cardiovascular prevention and/or kidney protection? Place to debate

- Krempf M. , et al.

20. Rapid detection of insulin by immune-enrichment with silicon-nanoparticle-assisted MALDI-TOF MS

- Wang Y. , et al.

21. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

- Mosenzon O. , et al.

22. Human insulin versus insulin analogues: A true companion forgotten

- Abdi H. , et al.

23. Reappraisal of metformin: Less restrictions and more potential indications

- Scheen A.J. , et al.